Pfizer 2Q Revenues: $11.1 billion (-6%) 2Q Earnings: $1.3 billion (-48%) YTD Revenues: $23.6 billion (flat) YTD Earnings: $4.7 billion (-29%) Comments: Worldwide pharmaceutical revenues for the quarter were $10.1 billion, down 7%. The following drugs performed well in the quarter and YTD respectively: Celebrex, 1% and 12%; Lyrica, 49% and 73%; Detrol/Detrol LA, 5% and 11%; Zyvox, 21% and 30%; Geodon/Zeldox, 8% and 14%; Caduet, 50% and 69%; Vfend, 23% and 25%; and Aromasin, 22...